Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) EBT Margin (2019 - 2025)

Bioadaptives' EBT Margin history spans 7 years, with the latest figure at 7896.29% for Q4 2025.

  • Quarterly results put EBT Margin at 7896.29% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 8860.69% (down 370612.0% YoY), and the annual figure for FY2025 was 8523.35%, down 142602.0%.
  • EBT Margin for Q4 2025 was 7896.29% at Bioadaptives, up from 8193.05% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 265.17% in Q4 2023 to a low of 27113.63% in Q2 2024.
  • The 5-year median for EBT Margin is 5059.32% (2022), against an average of 5726.46%.
  • The sharpest move saw EBT Margin crashed -2248764bps in 2024, then soared 2220794bps in 2025.
  • Year by year, EBT Margin stood at 2326.72% in 2021, then plummeted by -200bps to 6990.96% in 2022, then surged by 104bps to 265.17% in 2023, then plummeted by -10325bps to 27113.63% in 2024, then surged by 71bps to 7896.29% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 7896.29%, 8193.05%, and 4905.68% for Q4 2025, Q3 2025, and Q2 2025 respectively.